By calculating estimated daily tumor growth using the formula: (Tumor volume at Day-42 - Tumor volume at Day-0)/42, we found that the growth of HBO1 shRNA-injected pOS-1 xenografts was significantly inhibited (Figure 6B). Here, KAT7 is linked to neoplasm.